Search hospitals
>
North Carolina
>
Kinston
TG Therapeutics Investigational Trial Site
Claim this profile
Kinston, North Carolina 28501
Conducts research for Chronic Lymphocytic Leukemia
Conducts research for Non-Hodgkin's Lymphoma
Conducts research for Diffuse Large B-Cell Lymphoma
Conducts research for Follicular Lymphoma
Conducts research for MALT Lymphoma
3 reported clinical trials
0 medical researchers
Summary
TG Therapeutics Investigational Trial Site is a medical facility located in Kinston, North Carolina. This center is recognized for care of Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, MALT Lymphoma and other specialties. TG Therapeutics Investigational Trial Site is involved with conducting 3 clinical trials across 8 conditions. There are 0 research doctors associated with this hospital, such as .
Top PIs
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at TG Therapeutics Investigational Trial Site?
TG Therapeutics Investigational Trial Site is a medical facility located in Kinston, North Carolina. This center is recognized for care of Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, MALT Lymphoma and other specialties. TG Therapeutics Investigational Trial Site is involved with conducting 3 clinical trials across 8 conditions. There are 0 research doctors associated with this hospital, such as .
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.